Trevi Therapeutics, Inc. insider trading

TRVINASDAQ

$13.72-0.19 (-1.37%)as of Oct 5, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 6, 2025 to Oct 5, 2026. Price (+37.9%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22

Unlock quarterly net flow

Key players

SDScott D. Sandell10% Owner9.2803%of company
ABAli Behbahani10% Owner9.2803%of company
CCCarmen Chang10% Owner9.2803%of company
PEPaul Edward Walker10% Owner9.2803%of company
FAFlorence Anthony A. Jr.10% Owner9.2803%of company
MMMohamad Makhzoumi10% Owner9.2803%of company
FBForest Baskett10% Owner8.6143%of company
TSThomas SciasciaChief Scientific Officer0.1554%of company
JLJennifer L. GoodPresident & CEO0.1497%of company
FSFarrell SimonChief Commercial Officer0.054%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
No qualifying insider activity was found for the selected filters.

End of history · 0 transactions